<div>Little Ottilie’s world changed forever in a matter of days.
</div>
<div><br />
</div>
<div>On 8th May, we took Ottie to the doctors due to a small lump on her temple which hadn’t reduced. The doctor urgently referred her to hospital where she was given a CT scan. That’s when our worst nightmare started and our lives changed forever. They found a large and aggressive tumour in Ottilie’s skull, pressing significantly against her brain.
</div>
<div><br />
</div>
<div>We were blue lighted to Nottingham QMC for further testing, where the devastating diagnosis followed: high-risk neuroblastoma, a rare and aggressive childhood cancer that we learned had already spread to her skull, spine and bone marrow. The odds are not in Ottie's favour, with survival currently sitting between 30-50%. But, there is chance and that’s all we have.
</div>
<div><br />
</div>
<div>Before even reaching her second birthday, Ottie has already endured five general anaesthetics, surgery to her skull, countless scans and tests, a central line procedure, bone marrow biopsies, hearing tests, eye examinations and heart scans.
</div>
<div><br />
</div>
<div>On 21st May, she began emergency intensive chemotherapy, the beginning of an incredibly long and gruelling treatment journey.
</div>
<div><br />
</div>
<div>Over the next 18 months, Ottilie will face further intensive chemotherapy, surgery, blood transfusions, stem cell transplant, radiotherapy and immunotherapy. Despite everything she has already been through in the past two weeks, she continues to fight with unbelievable strength and a smile, every single day. Anyone that knows Ottilie will tell you what a strong, independent, sassy little character she is!!
</div>
<div><br />
</div>
<div>Even after all this treatment and the severe side effects that come with it, neuroblastoma carries a frighteningly high relapse rate. If the cancer returns, survival chances drop dramatically.
</div>
<div><br />
</div>
<div>There is hope in the form of a promising vaccine treatment currently being trialled at Memorial Sloan Kettering Cancer Center in New York, designed to help prevent neuroblastoma returning. Unfortunately, this treatment is not currently available in the UK, so we are fundraising to give Ottilie access to this and any other potentially life-saving treatments available in the future.
</div>
<div><br />
</div>
<div>The funds raised will go towards Ottilie’s treatment, travel and medical costs, improving her quality of life, and supporting us as a family as we navigate the hardest fight of our lives.
</div>
<div><br />
</div>
<div>As a family, asking for help does not come naturally, but we need to know we have done absolutely everything possible to give our beautiful little girl the best chance of survival.
</div>
<div><br />
</div>
<div>Every donation, no matter how small, truly means the world to us. If any funds raised are not needed for Ottilie’s treatment, they will be donated directly to neuroblastoma research to help other children and families facing this devastating disease.
</div>
<div><br />
</div>
<div>Thank you for reading, sharing, donating, and standing beside Ottilie and us all in her fight. It is appreciated more than you will ever know.
</div>
<div><br />
</div>
<div>All our love,
</div>
<div><br />
</div>
<div>James, Sophie, Archie &amp; Ottilie
</div>

Stuart Nicholson

Janet Cullen

Anonymous

Dorothy Hopton

Charlotte Feldhoff

Eleanor Duncombe

Randy Lane

Jacqueline Heath

Nathan Morris

Hannah Emery

Jane McCormack

Claire Brockie

Christine Roberts

Amanda Jones

Jo Elliott

Remi Ifederu

Ottilie’s Neuroblastoma Journey ❤️

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Ottilie’s Neuroblastoma Journey ❤️

Still £86,264 to go. Help us build momentum.